Measuring access to essential medicines in the sustainable development goals.
作者信息
Jenei Kristina, Wirtz Veronika J
机构信息
Department of Health Policy, London School of Economics and Political Science, Houghton Street, LondonWC2A 2AE, England.
World Health Organization Collaborating Center in Pharmaceutical Policy, Boston University School of Public Health, Boston, United States of America.
出版信息
Bull World Health Organ. 2024 Aug 1;102(8):555-555A. doi: 10.2471/BLT.24.291399.
Abstract
摘要
相似文献
1
Measuring access to essential medicines in the sustainable development goals.衡量可持续发展目标中基本药物的可及性。
Bull World Health Organ. 2024 Aug 1;102(8):555-555A. doi: 10.2471/BLT.24.291399.
2
Improving global access to medicines for non-communicable diseases.改善全球非传染性疾病药品的可及性。
Lancet Glob Health. 2014 Oct;2(10):e561-2. doi: 10.1016/S2214-109X(14)70189-5.
3
A global accountability mechanism for access to essential medicines.一个获取基本药物的全球问责机制。
Lancet. 2018 Dec 8;392(10163):2418-2420. doi: 10.1016/S0140-6736(18)32986-6.
4
Essential medicines twenty-five years on: closing the access gap.25年来的基本药物：缩小可及差距
Health Policy Plan. 2003 Mar;18(1):1-3. doi: 10.1093/heapol/18.1.1.
5
Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.在获取用于治疗非传染性疾病和精神健康状况的基本药物和保健产品方面存在的差距。
Bull World Health Organ. 2020 Sep 1;98(9):582-582A. doi: 10.2471/BLT.20.272658.
6
Patently necessary: improving global access to essential medicines.显然必要：改善全球基本药物的可及性。
CMAJ. 2003 Dec 9;169(12):1257, 1259.
7
Essential medicines out of reach for most people.大多数人无法获得基本药物。
Indian J Med Sci. 2008 Dec;62(12):520-1.
8
Access to essential medicines in 195 countries: A human rights approach to sustainable development.195 个国家获取基本药物的情况：以人权为手段促进可持续发展。
Glob Public Health. 2019 Mar;14(3):431-444. doi: 10.1080/17441692.2018.1515237. Epub 2018 Sep 6.
9
Accelerating access to medicines in a changing world.在不断变化的世界中加速药品可及性。
Bull World Health Organ. 2020 Sep 1;98(9):641-643. doi: 10.2471/BLT.19.249664. Epub 2020 Jul 8.
10
Access denied to essential medicines in developing world.发展中世界获取基本药物受限。
Lancet Infect Dis. 2002 Dec;2(12):711. doi: 10.1016/s1473-3099(02)00466-8.
引用本文的文献
1
Time and cost involved in measuring access to medicines: the case of Albania.衡量药品可及性所涉及的时间和成本：阿尔巴尼亚的案例
BMC Res Notes. 2025 Mar 10;18(1):104. doi: 10.1186/s13104-025-07168-5.
2
The Political Economy of the World Health Organization Model Lists of Essential Medicines.世界卫生组织基本药物示范清单的政治经济学
Milbank Q. 2025 Mar;103(1):52-99. doi: 10.1111/1468-0009.70001. Epub 2025 Feb 27.
本文引用的文献
1
SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children.可持续发展目标指标 3.b.3-衡量儿童获得药物机会的稳健性及其挑战分析。
BMC Health Serv Res. 2023 Jun 3;23(1):574. doi: 10.1186/s12913-023-09554-w.
2
Missing data on accessibility of children's medicines.儿童用药可及性数据缺失。
Bull World Health Organ. 2022 Oct 1;100(10):636-642. doi: 10.2471/BLT.22.288137. Epub 2022 Sep 2.
3
Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services.监测可持续发展目标中的全民健康覆盖：基本卫生服务指数的制定和基准数据。
Lancet Glob Health. 2018 Feb;6(2):e152-e168. doi: 10.1016/S2214-109X(17)30472-2. Epub 2017 Dec 13.
4
How the MDGs gave up on measuring access to medicines.千年发展目标是如何放弃衡量药品可及性的。
Lancet Glob Health. 2016 May;4(5):e296-7. doi: 10.1016/S2214-109X(16)00066-8.
Zotero 插件